HIV/AIDS and Infectious Diseases
Show Only Open Trials
1.
BMT CTN 0903 - Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals
- Study Status: Open to Enrollment
- Sponsor: BMT-CTN
- Disease Status and/or Stage: Hematologic Cancers and Myelosysplastic Syndromes in HIV-Positive People
- Protocol ID: BMT CTN 0903
2.
HPTN 069: Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men and Women
- Study Status: Open to Enrollment
- Sponsor: NIAID
- Disease Status and/or Stage: HIV-Negative, At-Risk Men Who Have Sex with Men and At-Risk Women
- Protocol ID: HPTN 069
3.
Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir (VIKING-4)
- Study Status: Open to Enrollment
- Sponsor: ViiV Healthcare
- Disease Status and/or Stage: Integrase Inhibitor Resistant
4.
A5298: A Randomized, Double-Blinded, Placebo-Controlled, Phase III Trial of the Quadrivalent HPV Vaccine to Prevent Anal Human Papillomavirus Infection in HIV-Infected Men and Women
- Study Status: Open to Enrollment
- Sponsor: NIAID
- Disease Status and/or Stage: HIV-Positive Men and Women
- Protocol ID: A5298
5.
A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects
- Study Status: Open to Enrollment
- Sponsor: ACTG
- Protocol ID: A5295
6.
A5294: A Prospective, Phase III, Open-Label Study of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects
- Study Status: Open to Enrollment
- Sponsor: NIAID
- Disease Status and/or Stage: HIV/Hepatitis C Co-Infection
7.
START (STRATEGIC TIMING OF ANTIRETROVIRAL TREATMENT)
- Study Status: Open to Enrollment
- Sponsor: NIH
- Disease Status and/or Stage: HIV Antiretroviral Naive (Have Not Taken HIV Medications)
